SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-004994
Filing Date
2024-04-12
Accepted
2024-04-12 07:01:47
Documents
13
Period of Report
2024-04-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K qure-20240409x8k.htm   iXBRL 8-K 29563
  Complete submission text file 0001558370-24-004994.txt   145330

Data Files

Seq Description Document Type Size
2 EX-101.SCH qure-20240409.xsd EX-101.SCH 3405
3 EX-101.LAB qure-20240409_lab.xml EX-101.LAB 15216
4 EX-101.PRE qure-20240409_pre.xml EX-101.PRE 9966
16 EXTRACTED XBRL INSTANCE DOCUMENT qure-20240409x8k_htm.xml XML 4599
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 24839952
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)